knowledge -WSS

knowledge

author：knowledge 2025-09-05 11:32:29 - browse：7635

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Man who had jail sentence commuted by Trump arrested again

WSS

How dance can help health care workers heal from trauma

Second xenotransplant done with gene

TikTok cracks down on users posting about weight loss drugs

Seattle police shoot person suspected in downtown stabbing

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Emergency workers more likely to restrain Black patients: study

leisure time

knowledge

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Stanford updates investigation of president’s past research

Walensky prepares to leave CDC — and Congress — behind

Emergency workers more likely to restrain Black patients: study

Activists slam private health insurers over coverage restrictions

Resistance to cancer drugs: A new genetic explanation

Tori Bowie and the unacceptable rates of Black maternal death

Microbiome research is starting to find links to chronic diseases

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How AI helped researchers track recovery from depression

explore

Medical experts are missing from AI regulatory conversations

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

CDC advisers recommend seasonal use of Pfizer RSV shot

Stanford updates investigation of president’s past research

Seattle police shoot person suspected in downtown stabbing

Drug for rare kidney disease narrowly misses mark in clinical trial

hotspot

hotspot

hotspot

focus